= 940310-85-0 [标题:Reaction Conditions 标题:Preparation Of Heteroarylaminobenzamides As Receptor Tyrosine Kinase Inhibitors For Treatment Of Protein Kinase Modulation-Responsive Disease Or Disorder 参考文献:United States]
940516-19-8 + 91092-05-6 = 940310-85-0 反应条件:1.1 Reagents: Cesium Carbonate Catalysts: Tris(Dibenzylideneacetone)Dipalladium,1,1′-(9,9-Dimethyl-9H-Xanthene-4,5-Diyl)Bis[1,1-Diphenylphosphine] Solvents: 1,4-Dioxane; 4 H,Rt -> 120 °C 标题:Nvp-Bhg712: Effects Of Regioisomers On The Affinity And Selectivity Toward The Ephrin Family 作者:Troester,Alix; Heinzlmeir,Stephanie; Berger,Benedict-Tilman; Gande,Santosh L.; Saxena,Krishna; Et Al 参考文献:Chemmedchem 日期:2018 卷标:13(16) 页码:1629-1633]
1692-25-7 + 2271317-00-9 = 940310-85-0 反应条件:1.1 Reagents: Sodium Carbonate Catalysts: Dichloro[1,1′-Bis(Diphenylphosphino)Ferrocene]Palladium(Ii) Dichloromethane Addu... Solvents: 1,4-Dioxane,Water; 100 °C 标题:Process For Preparation Of Substituted Penta- And Hexa-Heterocyclic Compounds,Drug Combination And Use Thereof 参考文献:China
专利号:US-2025289827-A1 优先权日:2022-12-02 标 题:Morphic forms of a mutant braf degrader and methods of manufacture thereof 发明人:YU ROBERT T; HE MINSHENG; SCHNADERBECK MATTHEW J; KREGER BRIDGET; POLLOCK ROY MACFARLANE; JIANG SIYI; LI MEIQI; CHEN BOLU; LU JIANNAN 权利人:C4 THERAPEUTICS INC 摘要:Advantageous isolated morphic forms of (3R)-3-[6-[2-cyano-3-[[ethyl(methyl)sulfamoyl]amino]-6-fluorophenoxy]-4-oxoquinazolin-3-yl]-8-[2-[1-[3-(2,4-dioxo-1,3-diazinan-1-yl)-5-fluoro-1-methylindazol-6-yl]-4-hydroxypiperidin-4-yl]acetyl]-1-oxa-8-azaspiro[4.5]decane (Compound 1), which is a mutant BRAF degrader, and methods to prepare Compound 1 morphic forms for therapeutic applications are provided in the invention. The invention also provides improved methods for the synthesis of Compound 1, new pharmaceutical compositions comprising Compound 1, and new uses of Compound 1.
1: Li T, Wang H, Liu R, Wang X, Huang L, Wu Z, Yin X, Zou S, Duan P. The role of EphB4/ephrinB2 signaling in root repair after orthodontically-induced root resorption. Am J Orthod Dentofacial Orthop. 2021 Mar;159(3):e217-e232. doi: 10.1016/j.ajodo.2020.07.035. Epub 2021 Jan 22. 25(21):5115. doi: 10.3390/molecules25215115. 3: Broggini T, Piffko A, Hoffmann CJ, Ghori A, Harms C, Adams RH, Vajkoczy P, Czabanka M. Ephrin-B2-EphB4 communication mediates tumor-endothelial cell interactions during hematogenous spread to spinal bone in a melanoma metastasis model. Oncogene. 2020 Nov;39(47):7063-7075. doi: 10.1038/s41388-020-01473-y. Epub 2020 Sep 28. 10:1377. doi: 10.3389/fonc.2020.01377.
合成参考文献
参考文献:10.1124/mol.119.115964 摘要:Lee TD, Lee OW, Brimacombe KR, Chen L, Guha R, Lusvarghi S, Tebase BG, Klumpp-Thomas C, Robey RW, Ambudkar SV, Shen M, Gottesman MM, Hall MD. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular Pharmacology. 2019 Nov;96(5):629–40. doi: 10.1124/mol.119.115964.